Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOTRONIK - Safety and Clinical PerFormance of the Drug Eluting Absorbable Metal Scaffold (DREAMS 2nd Generation) in the Treatment of Subjects With de NOvo Lesions in NatiVE Coronary Arteries: BIOSOLVE-II

NCT01960504 is registered in ClinicalTrials.gov with Biotronik AG as lead sponsor.

NCT NCT01960504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01960504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOTRONIK - Safety and Clinical PerFormance of the Drug Eluting Absorbable Metal Scaffold (DREAMS 2nd Generation) in the Treatment of Subjects With de NOvo Lesions in NatiVE Coronary Arteries: BIOSOLVE-II
Lead sponsor
Biotronik AG
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2013
Completion date
May 31, 2020
Enrollment
123 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, coronary artery stenosis